Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
September 12, 2019 - Ardelyx announced the FDA approval of Ibsrela (tenapanor), for treatment of irritable bowel syndrome with constipation (IBS-C) in adults.
